Full Text View
Tabular View
No Study Results Posted
Related Studies
Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma
This study is currently recruiting participants.
Study NCT00068146   Information provided by National Institutes of Health Clinical Center (CC)
First Received: September 9, 2003   Last Updated: August 24, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lymphoproliferative Disorders
Lymphoma
Additional conditions recognized in this trial
Anemia, Hemolytic, Autoimmune
Disease
Syndrome
More general conditions related to this trial
Anemia
Anemia, Hemolytic
Autoimmune Diseases
Hematologic Diseases
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Neoplasms
Neoplasms by Histologic Type
Pathologic Processes
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services